SELPLG and cancer: There is increasing evidence that CD162 may play a role in cancer cell interactions with their environment (Dimitroff et al., 2005; Raes et al., 2007; Zheng et al., 2013; Heidemann et al., 2014; Tinoco et al., 2016; Li et al., 2017; Spertini et al., 2019).